Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26) 26
humans (20) 20
female (15) 15
adult (11) 11
analysis (11) 11
male (9) 9
middle aged (9) 9
oncology (8) 8
research (8) 8
pregnancy (7) 7
abridged index medicus (6) 6
aged (6) 6
studies (6) 6
cancer (5) 5
internal medicine (5) 5
medicine (5) 5
mortality (5) 5
ribavirin (5) 5
safety (5) 5
young adult (5) 5
adolescent (4) 4
article (4) 4
chemotherapy (4) 4
drug therapy, combination (4) 4
hcv (4) 4
hepatitis (4) 4
in-vitro (4) 4
methods (4) 4
open-label (4) 4
prevalence (4) 4
risk (4) 4
anilides - administration & dosage (3) 3
antiviral agents (3) 3
antiviral agents - therapeutic use (3) 3
carbamates - administration & dosage (3) 3
care and treatment (3) 3
complications (3) 3
dasabuvir (3) 3
double-blind method (3) 3
endocrinology & metabolism (3) 3
exosomes (3) 3
flow cytometry (3) 3
genotype (3) 3
genotype & phenotype (3) 3
head and neck cancer (3) 3
hepacivirus - genetics (3) 3
hepatitis c, chronic - drug therapy (3) 3
infections (3) 3
liver cirrhosis (3) 3
macrocyclic compounds - administration & dosage (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine, general & internal (3) 3
motivation (3) 3
nutrition & dietetics (3) 3
obesity (3) 3
oncology, experimental (3) 3
patient education (3) 3
patient education as topic (3) 3
patients (3) 3
pharmacology & pharmacy (3) 3
preeclampsia (3) 3
randomization (3) 3
research article (3) 3
research design (3) 3
risk factors (3) 3
ritonavir - administration & dosage (3) 3
sofosbuvir (3) 3
survival (3) 3
trial (3) 3
virus diseases (3) 3
womens health (3) 3
éducation des patients (3) 3
age (2) 2
aged, 80 and over (2) 2
alleles (2) 2
antiviral agents - administration & dosage (2) 2
association (2) 2
bacterial pneumonia (2) 2
biochemical phenomena, metabolism, and nutrition (2) 2
biology (2) 2
birth-weight (2) 2
breast cancer (2) 2
breast neoplasms - genetics (2) 2
burden (2) 2
cancer therapies (2) 2
clinical medicine (2) 2
clinical trials (2) 2
cohort studies (2) 2
confidence intervals (2) 2
consensus (2) 2
data collection (2) 2
digestive system diseases (2) 2
drug dosages (2) 2
ethics (2) 2
evaluation (2) 2
food (2) 2
gastroenterology & hepatology (2) 2
genetic predisposition to disease (2) 2
gynecology (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Distribution of Cervical Lymph Node Metastases from Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification using HPV and Smoking Status
by Amsbaugh, Mark J., MD and Yusuf, Mehran, BA and Cash, Elizabeth, PhD and Silverman, Craig, MD and Wilson, Elizabeth, RN and Bumpous, Jeffrey, MD and Potts, Kevin, MD and Perez, Cesar, MD and Bert, Robert, MD PhD and Redman, Rebecca, MD and Dunlap, Neal, MD
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016
Abstract Purpose/Objective(s) Factors contributing to clinical presentation of oropharyngeal squamous cell carcinoma (OPSCC) in the era of risk stratification... 
Radiology | Hematology, Oncology and Palliative Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
by Hézode, Christophe, Dr Prof and Asselah, Tarik, Prof and Reddy, K Rajender, Prof and Hassanein, Tarek, Prof and Berenguer, Marina, MD and Fleischer-Stepniewska, Katarzyna, MD and Marcellin, Patrick, Prof and Hall, Coleen, MS and Schnell, Gretja, PhD and Pilot-Matias, Tami, PhD and Mobashery, Niloufar, MD and Redman, Rebecca, MD and Vilchez, Regis A, MD and Pol, Stanislas, Prof
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Summary Background Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global HCV infections. Because interferon-containing treatments for genotype 4... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ABT-450/R-OMBITASVIR | DASABUVIR | SOFOSBUVIR | HCV | INHIBITOR | LEDIPASVIR | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Carbamates - administration & dosage | Hepatitis C, Chronic - drug therapy | Aspartate Aminotransferases - drug effects | Young Adult | Alanine Transaminase - drug effects | Anilides - administration & dosage | Hepatitis C, Chronic - enzymology | Ribavirin - administration & dosage | Adolescent | Adult | Female | Aged | Macrocyclic Compounds - administration & dosage | Drug Therapy, Combination | Virus diseases | Care and treatment | Protease inhibitors | Proteases | Liver | Biological response modifiers | Hepatitis C virus | Health aspects | Ribavirin | Hepatitis | Genotype & phenotype | Infections | Drug therapy | Liver cirrhosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects
by Zha, Jiuhong, PhD and Badri, Prajakta S., PhD and Ding, Bifeng, MS and Uchiyama, Naotaka, PhD and Alves, Katia, MD and Rodrigues-Jr, Lino, MD and Redman, Rebecca, MD and Dutta, Sandeep, PhD and Menon, Rajeev M., PhD
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 11, pp. 2560 - 2571
Abstract Purpose The 2 direct-acting antiviral combination (2D) of ombitasvir and paritaprevir (coadministered with ritonavir) is being evaluated for the... 
Internal Medicine | Medical Education | drug interactions | ursodeoxycholic acid | ombitasvir | glycyrrhizin | paritaprevir | ritonavir | Key words drug interactions | TRIAL | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | BIOAVAILABILITY | Ursodeoxycholic Acid - administration & dosage | Glycyrrhizic Acid - administration & dosage | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Humans | Japan | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Young Adult | Drug Interactions | Anilides - administration & dosage | Adult | Macrocyclic Compounds - administration & dosage | Drug Therapy, Combination | Complications and side effects | Antiviral agents | Ursodiol | Hepatitis C | Hepatitis C virus | Drug interactions | Proteins | Studies | Hepatitis | Genotype & phenotype | Liver diseases | Acids | Rodents | Liver cirrhosis | Drug dosages | Bile
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text HPV: A factor in organ preservation for locally advanced larynx and hypopharynx cancer?
by Shaughnessy, Joseph N., MD and Farghaly, Hanan, MD and Wilson, Liz, BSN and Redman, Rebecca, MD and Potts, Kevin, MD and Bumpous, Jeffrey, MD and Silverman, Craig, MD and Dunlap, Neal E., MD
American Journal of Otolaryngology--Head and Neck Medicine and Surgery, ISSN 0196-0709, 2014, Volume 35, Issue 1, pp. 19 - 24
Abstract Purpose/objective To assess the interaction of HPV/p16 status and therapy rendered in patients with locally advanced squamous cell carcinoma of the... 
Otolaryngology | Surgery | SURVIVAL | TRIAL | HEAD | INDUCTION CHEMOTHERAPY | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | RISK | HUMAN-PAPILLOMAVIRUS | NECK | RADIOTHERAPY | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Laryngeal Neoplasms - surgery | Prognosis | Hypopharyngeal Neoplasms - virology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Hypopharyngeal Neoplasms - mortality | Human papillomavirus 16 - metabolism | Disease-Free Survival | Human papillomavirus 16 - isolation & purification | Squamous Cell Carcinoma of Head and Neck | Laryngeal Neoplasms - mortality | Otorhinolaryngologic Surgical Procedures - methods | Aged, 80 and over | Adult | Female | Aged | Laryngeal Neoplasms - virology | Papillomavirus infections | Squamous cell carcinoma | Confidence intervals | Human papillomavirus | Chemotherapy | Preservation | Management decisions | Colleges & universities | Larynx | Radiation therapy | Head & neck cancer | Multivariate analysis | Cancer therapies | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
by Dragovic, Rebecca A., MSc and Gardiner, Christopher, PhD and Brooks, Alexandra S., MD and Tannetta, Dionne S., PhD and Ferguson, David J.P., PhD and Hole, Patrick, PhD and Carr, Bob, PhD and Redman, Christopher W.G., MD, FRCP and Harris, Adrian L., MD, PhD, FRCP and Dobson, Peter J., PhD, FInstP, CPhys and Harrison, Paul, PhD and Sargent, Ian L., PhD
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2011, Volume 7, Issue 6, pp. 780 - 788
Abstract Cellular microvesicles and nanovesicles (exosomes) are involved in many disease processes and have major potential as biomarkers. However,... 
Internal Medicine | Nanoparticle Tracking Analysis | Flow Cytometry | Microvesicles | Exosomes | Microparticles | MEDICINE, RESEARCH & EXPERIMENTAL | NORMAL-PREGNANCY | DYNAMIC LIGHT-SCATTERING | NANOSCIENCE & NANOTECHNOLOGY | SYNCYTIOTROPHOBLAST MICROPARTICLES | PREECLAMPSIA | PLASMA | CIRCULATING MICROPARTICLES | FLOW-CYTOMETRY | CHYLOMICRONS | Nanoparticles - analysis | Cell-Derived Microparticles - genetics | Nanotechnology - methods | Humans | Fluorescence | Cell-Derived Microparticles - chemistry | Particle Size | Pregnancy | Phenotype | Placenta - cytology | Female | Cell-Derived Microparticles - ultrastructure | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis
by Grivel, Margaux M and Leong, Wei and Masucci, Michael D and Altschuler, Rebecca A and Arndt, Leigh Y and Redman, Samantha L and Yang, Lawrence H and Brucato, Gary and Girgis, Ragy R
Schizophrenia Research, ISSN 0920-9964, 05/2018, Volume 195, pp. 549 - 553
Recent research suggests that trauma history (TH) is a strong socio-environmental risk factor for the development of psychosis. While reported rates of... 
Psychosis | Suicidal behavior | Suicidal ideation | Trauma | Attenuated psychosis syndrome | PSYCHIATRY | ULTRA-HIGH-RISK | SCHIZOPHRENIA | DISORDERS | SYMPTOMS | PREVALENCE | CANNABIS USE | INCREASE | CHILDHOOD SEXUAL-ABUSE | IDEATION | Humans | Psychotic Disorders - psychology | Wounds and Injuries - psychology | Probability | Male | Suicidal Ideation | Prodromal Symptoms | Suicide, Attempted - psychology | Young Adult | Psychiatric Status Rating Scales | Adolescent | Adult | Female | Cohort Studies | Sleep disorders | Usage | Risk factors | Post-traumatic stress disorder | Attenuated Psychosis Syndrome | Suicidal Behavior
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
by Burtness, Barbara and Harrington, Kevin J and Harrington, Kevin and Greil, Richard and Soulières, Denis and Tahara, Makoto and de Castro, Gilberto and Psyrri, Amanda and Basté, Neus and Neupane, Prakash and Bratland, Åse and Bratland, Aase and Fuereder, Thorsten and Hughes, Brett G M and Hughes, Brett and Mesía, Ricard and Ngamphaiboon, Nuttapong and Rordorf, Tamara and Wan Ishak, Wan Zamaniah and Hong, Ruey-Long and González Mendoza, René and Roy, Ananya and Zhang, Yayan and Gumuscu, Burak and Cheng, Jonathan D and Jin, Fan and Rischin, Danny and Lerzo, Guillermo and Tatangelo, Marcelo and Varela, Mirta and Zarba, Juan Jose and Boyer, Michael and Gan, Hui and Gao, Bo and Mallesara, Girish and Taylor, Anne and Burian, Martin and Barrios, Carlos Henrique and de Castro Junior, Dalvaro Oliveira and Castro, Gilberto and Franke, Fabio Andre and Girotto, Gustavo and Lima, Iane Pinto Figueiredo and Nicolau, Ulisses Ribaldo and Pinto, Gustavo Dix Junqueira and Santos, Lucas and Victorino, Ana-Paula and Chua, Neil and Couture, Felix and Gregg, Richard and Hansen, Aaron and Hilton, John and McCarthy, Joy and Soulieres, Denis and Ascui, Rodrigo and Gonzalez, Pablo and Villanueva, Luis and Torregroza, Marco and Zambrano, Angela and Holeckova, Petra and Kral, Zdenek and Melichar, Bohuslav and Prausova, Jana and Vosmik, Milan and Andersen, Maria and Gyldenkerne, Niels and Jurgens, Hannes and Putnik, Kadri and Reinikainen, Petri and Gruenwald, Viktor and Laban, Simon and Aravantinos, Gerasimos and Boukovinas, Ioannis and Georgoulias, Vassilis and Kwong, Dora and Al-Farhat, Yousuf and Csoszi, Tibor and Erfan, Jozsef and Horvai, Geza and Landherr, Laszlo and Remenar, Eva and Ruzsa, Agnes and Szota, Judit and Billan, Salem and Gluck, Iris and Gutfeld, Orit and Popovtzer, Aron and Benasso, Marco and Bui, Simona and Ferrari, Vittorio and Licitra, Lisa and Nole, Franco and Fujii, Takashi and Fujimoto, Yasushi and Hanai, Nobuhiro and Hara, Hiroki and Matsumoto, Koji and Mitsugi, Kenji and Monden, Nobuya and Nakayama, Masahiro and ...
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1915 - 1928
Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) expression associated with improved... 
Chemotherapy | Squamous cell carcinoma | Metastasis | Analysis | Cancer | Medical research | 5-Fluorouracil | Mortality | Oncology | Survival | Metastases | Population (statistical) | Pembrolizumab | Hypotheses | Randomization | Motivation | Platinum | Cell death | PD-L1 protein | Population | Head and neck cancer | Ligands | Larynx | Safety | Apoptosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
by Hausenloy, DJ and Kharbanda, RK and Moller, UK and Ramlall, M and Aaroe, J and Butler, R and Bulluck, H and Clayton, T and Dana, A and Dodd, M and Engstrom, T and Evans, R and Lassen, JF and Christensen, EF and Garcia-Ruiz, JM and Gorog, DA and Hjort, J and Houghton, RF and Ibanez, B and Knight, R and Lippert, FK and Lonborg, JT and Maeng, M and Milasinovic, D and More, R and Nicholas, JM and Jensen, LO and Perkins, A and Radovanovic, N and Rakhit, RD and Ravkilde, J and Ryding, AD and Schmidt, MR and Riddervold, IS and Sorensen, HT and Stankovic, G and Varma, M and Webb, I and Terkelsen, CJ and Greenwood, JP and Yellon, DM and Botker, HE and CONDI-2 ERIC-PPCI Investigators and CONDI-2/ERIC-PPCI Investigators
LANCET, ISSN 0140-6736, 10/2019, Volume 394, Issue 10207, pp. 1415 - 1424
Background Remote ischaemic conditioning with transient ischaemia and reperfusion applied to the arm has been shown to reduce myocardial infarct size in... 
LIMB | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | ISCHEMIA/REPERFUSION INJURY | TASK-FORCE | SIZE | ADJUNCT | ST-SEGMENT ELEVATION | CARDIOPROTECTION | Heart failure | Myocardial infarction | Heart | Stroke | Heart attacks | Cardiac conditioning | Mortality | Medical services | Patients | Clinical outcomes | Studies | Side effects | Randomization | Reperfusion | Motivation | Ischemia | Coronary vessels | Electrocardiography | Data collection | Death | Conditioning | Heart diseases | Veins & arteries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text 24th Annual Canadian Conference on HIV/AIDS Research/24e Congrès Annuel Canadien de Recherche sur le VIH/sida CAHR Committees / Comités de l’ACRV
The Canadian Journal of Infectious Diseases & Medical Microbiology, ISSN 1712-9532, 2015, Volume 26, Issue Suppl B, pp. 4B - 5B
Unir nos forces pour gagner la bataille contre le VIH | Combining Strengths in the Struggle Against HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Design of lifestyle intervention trials to prevent excessive gestational weight gain in women with overweight or obesity
by Clifton, Rebecca G and Evans, Mary and Cahill, Alison G and Franks, Paul W and Gallagher, Dympna and Phelan, Suzanne and Pomeroy, Jeremy and Redman, Leanne M and Van Horn, Linda and LIFE-Moms Res Grp and LIFE-Moms Research Group and Lund University and Genomics, Diabetes and Endocrinology and EpiHealth: Epidemiology for Health and Genomik, diabetes och endokrinologi and Genetic and Molecular Epidemiology and Genetisk och molekylär epidemiologi and Lunds universitet and EXODIAB: Excellence in Diabetes Research in Sweden
Obesity, ISSN 1930-7381, 02/2016, Volume 24, Issue 2, pp. 305 - 313
Objective The Lifestyle Interventions for Expectant Moms (LIFE‐Moms) Consortium is designed to determine, in pregnant women with overweight or obesity, whether... 
NUTRITION & DIETETICS | PRETERM PREDICTION | MATERNAL OBESITY | ENDOCRINOLOGY & METABOLISM | BODY-MASS INDEX | RISK | DIETARY | COMPLICATIONS | PREGNANCY OUTCOMES | BIRTH | ASSOCIATION | Life Style | United States | Humans | Infant | Postpartum Period | Counseling - organization & administration | Overweight - prevention & control | Pregnancy | Obesity - prevention & control | Adult | Female | Pregnancy Complications - prevention & control | Primary Prevention - organization & administration | Weight Gain | Studies | Obesity | Womens health | Socioeconomic factors | lifestyle modifications | pregnancy weight gain | Clinical Medicine | Obstetrics, Gynecology and Reproductive Medicine | Reproduktionsmedicin och gynekologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Characterisation of Syncytiotrophoblast Vesicles in Normal Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin
by Tannetta, Dionne S and Dragovic, Rebecca A and Gardiner, Chris and Redman, Christopher W and Sargent, Ian L
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e56754
Background: The placental syncytiotrophoblast releases micro and nanovesicles (STBM), into the maternal circulation in normal pregnancy and in increased... 
IN-VITRO | MICROVILLOUS MEMBRANES | MULTIDISCIPLINARY SCIENCES | ENDOTHELIAL-CELLS | SOLUBLE ENDOGLIN | EXOSOMES | MATERNAL CIRCULATION | FLOW CYTOMETER | GROWTH-FACTOR | MICROPARTICLES | PLACENTAL ALKALINE-PHOSPHATASE | Pre-Eclampsia - genetics | Phosphorylation | Trophoblasts - metabolism | Signal Transduction | Humans | Gene Expression Regulation | Receptors, Cell Surface - metabolism | Trophoblasts - pathology | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Antigens, CD - genetics | Pre-Eclampsia - pathology | Antigens, CD - metabolism | Placenta - metabolism | Pregnancy | Endoglin | Endothelium, Vascular - metabolism | Placenta - pathology | Protein Binding | Adult | Female | Receptors, Cell Surface - genetics | Vascular Endothelial Growth Factor Receptor-1 - genetics | Phosphatases | Pregnant women | Analysis | Preeclampsia | Transforming growth factors | Vascular endothelial growth factor | Endothelium | Flow cytometry | Alkaline phosphatase | Phosphatase | Western blotting | Nanoparticles | Placental alkaline phosphatase | Eclampsia | Hypertension | Antigens | Gynecology | Inflammation | Pre-eclampsia | Metabolism | Obstetrics | Biological activity | Cytometry | Placenta | Perfusion | Antiangiogenics | Antigenic characteristics | Ligands | Disruption | Endocrinology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis
by Kumada, Hiromitsu and Chayama, Kazuaki and Rodrigues, Lino and Suzuki, Fumitaka and Ikeda, Kenji and Toyoda, Hidenori and Sato, Ken and Karino, Yoshiyasu and Matsuzaki, Yasushi and Kioka, Kiyohide and Setze, Carolyn and Pilot‐Matias, Tami and Patwardhan, Meenal and Vilchez, Regis A and Burroughs, Margaret and Redman, Rebecca
Hepatology, ISSN 0270-9139, 10/2015, Volume 62, Issue 4, pp. 1037 - 1046
GIFT‐I is a phase 3 trial evaluating the efficacy and safety of a 12‐week regimen of coformulated ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) for... 
VIVO ANTIVIRAL ACTIVITY | IN-VITRO | DASABUVIR | 1 INFECTION | FIXED-DOSE COMBINATION | OPEN-LABEL | HCV | RESISTANCE PROFILE | RIBAVIRIN | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT-NAIVE PATIENTS | Double-Blind Method | Ritonavir - administration & dosage | Liver Cirrhosis - complications | Humans | Middle Aged | Hepacivirus - genetics | Genotype | Male | Carbamates - administration & dosage | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Asian Continental Ancestry Group | Anilides - administration & dosage | Female | Aged | Hepacivirus - classification | Macrocyclic Compounds - administration & dosage | Drug Combinations | Confidence intervals | Hepatitis | Genotype & phenotype | Liver cirrhosis | Human immunodeficiency virus--HIV | Viral Hepatitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights